DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 1 filers reported holding DECIBEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,902 | +27.5% | 494,071 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,492 | +47.3% | 494,071 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $1,013 | -99.9% | 494,071 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $1,709,000 | -17.8% | 494,071 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $2,080,000 | +38.5% | 494,071 | 0.0% | 0.01% | +66.7% |
| Q1 2022 | $1,502,000 | -34.6% | 494,071 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $2,297,000 | -39.7% | 494,071 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $3,809,000 | -10.4% | 494,071 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $4,249,000 | -24.3% | 494,071 | 0.0% | 0.01% | -30.8% |
| Q1 2021 | $5,613,000 | – | 494,071 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $27,001,000 | 4.71% |
| Samsara BioCapital, LLC | 826,422 | $7,107,000 | 0.88% |
| Orbimed Advisors | 4,945,192 | $42,529,000 | 0.43% |
| Foresite Capital Management IV, LLC | 297,711 | $2,560,000 | 0.35% |
| Alphabet Inc. | 1,636,258 | $14,072,000 | 0.29% |
| Casdin Capital, LLC | 1,171,421 | $10,074,000 | 0.26% |
| HARVARD MANAGEMENT CO INC | 328,798 | $2,828,000 | 0.16% |
| Tibra Equities Europe Ltd | 43,400 | $373,000 | 0.12% |
| AlphaCentric Advisors LLC | 45,000 | $387,000 | 0.10% |
| Bronte Capital Management Pty Ltd. | 159,462 | $1,371,000 | 0.10% |